Marine Polyether Phycotoxin Palytoxin Induces Apoptotic Cell Death via Mcl-1 and Bcl-2 Downregulation.


Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
06 Apr 2023
Historique:
received: 08 03 2023
revised: 28 03 2023
accepted: 28 03 2023
medline: 1 5 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: epublish

Résumé

Palytoxin is considered one of the most potent biotoxins. As palytoxin-induced cancer cell death mechanisms remain to be elucidated, we investigated this effect on various leukemia and solid tumor cell lines at low picomolar concentrations. As palytoxin did not affect the viability of peripheral blood mononuclear cells (PBMC) from healthy donors and did not create systemic toxicity in zebrafish, we confirmed excellent differential toxicity. Cell death was characterized by a multi-parametric approach involving the detection of nuclear condensation and caspase activation assays. zVAD-sensitive apoptotic cell death was concomitant with a dose-dependent downregulation of antiapoptotic Bcl-2 family proteins Mcl-1 and Bcl-xL. Proteasome inhibitor MG-132 prevented the proteolysis of Mcl-1, whereas the three major proteasomal enzymatic activities were upregulated by palytoxin. Palytoxin-induced dephosphorylation of Bcl-2 further exacerbated the proapoptotic effect of Mcl-1 and Bcl-xL degradation in a range of leukemia cell lines. As okadaic acid rescued cell death triggered by palytoxin, protein phosphatase (PP)2A was involved in Bcl-2 dephosphorylation and induction of apoptosis by palytoxin. At a translational level, palytoxin abrogated the colony formation capacity of leukemia cell types. Moreover, palytoxin abrogated tumor formation in a zebrafish xenograft assay at concentrations between 10 and 30 pM. Altogether, we provide evidence of the role of palytoxin as a very potent and promising anti-leukemic agent, acting at low picomolar concentrations in cellulo and in vivo.

Identifiants

pubmed: 37103372
pii: md21040233
doi: 10.3390/md21040233
pmc: PMC10143546
pii:
doi:

Substances chimiques

palytoxin OQ17NC0MOV
Myeloid Cell Leukemia Sequence 1 Protein 0
Proto-Oncogene Proteins c-bcl-2 0
Apoptosis Regulatory Proteins 0
bcl-X Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Blood. 2009 Jan 15;113(3):535-7
pubmed: 19008456
J Biol Chem. 2010 Jun 18;285(25):19615-24
pubmed: 20392693
PLoS One. 2012;7(6):e38139
pubmed: 22675515
Toxicon. 2011 Mar 1;57(3):429-39
pubmed: 20932855
Org Biomol Chem. 2007 Mar 21;5(6):897-9
pubmed: 17340004
Biochem Biophys Res Commun. 2003 May 9;304(3):433-5
pubmed: 12729576
Toxicon. 2011 Mar 1;57(3):440-8
pubmed: 21070801
J Cell Physiol. 2003 Mar;194(3):349-55
pubmed: 12548554
Int J Oncol. 1998 Oct;13(4):659-64
pubmed: 9735392
Phys Biol. 2008 Jul 29;5(3):036005
pubmed: 18663280
J Clin Invest. 2010 Oct;120(10):3421-31
pubmed: 20921628
Am J Physiol Cell Physiol. 2007 Jan;292(1):C24-32
pubmed: 16855216
Biosci Biotechnol Biochem. 2001 Nov;65(11):2585-8
pubmed: 11791741
Eur J Pharmacol. 2003 Mar 28;465(1-2):9-13
pubmed: 12650827
Chem Res Toxicol. 2015 Apr 20;28(4):752-64
pubmed: 25710824
Cell. 1998 Aug 21;94(4):481-90
pubmed: 9727491
Biochem Biophys Res Commun. 2011 Sep 30;413(3):460-4
pubmed: 21907705
FEBS Lett. 2005 Oct 24;579(25):5603-8
pubmed: 16213503
Toxicon. 2008 Mar 1;51(3):418-27
pubmed: 18067938
Leukemia. 2011 Apr;25(4):606-14
pubmed: 21233840
Blood. 2009 Jan 8;113(2):422-8
pubmed: 18845789
Toxicol Lett. 2014 Sep 17;229(3):440-50
pubmed: 25066017
Mol Cell Biol. 1999 Dec;19(12):8469-78
pubmed: 10567572
Zebrafish. 2009 Sep;6(3):275-80
pubmed: 19566408
Cell Death Dis. 2015 Jun 11;6:e1782
pubmed: 26068790
Mar Drugs. 2020 Jan 16;18(1):
pubmed: 31963113
Mar Drugs. 2010 Jun 30;8(7):2021-37
pubmed: 20714422
Lancet Oncol. 2013 May;14(6):e229-38
pubmed: 23639323
Science. 1971 Apr 30;172(3982):495-8
pubmed: 4396320
Cancer Lett. 2018 Dec 1;438:197-218
pubmed: 30205168
Leukemia. 2017 Mar;31(3):755-759
pubmed: 27872497
Cells. 2014 May 08;3(2):418-37
pubmed: 24814761
Cell Cycle. 2007 Jun 1;6(11):1288-92
pubmed: 17534146
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):386-8
pubmed: 12525688
J Immunol. 2001 Jan 15;166(2):966-72
pubmed: 11145674
Mar Drugs. 2012 Feb;10(2):477-496
pubmed: 22412814
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):153-8
pubmed: 14660795
Mar Drugs. 2021 May 21;19(6):
pubmed: 34063867
J Vis Exp. 2018 Jun 26;(136):
pubmed: 30010672
Nature. 2011 Mar 3;471(7336):104-9
pubmed: 21368833
Curr Opin Cell Biol. 2010 Dec;22(6):882-8
pubmed: 20889324
Leukemia. 2001 Apr;15(4):515-22
pubmed: 11368354
Cell Death Dis. 2020 Feb 7;11(2):109
pubmed: 32034134
Cell Death Differ. 2007 Jul;14(7):1237-43
pubmed: 17431418
Oncotarget. 2016 Apr 26;7(17):24027-49
pubmed: 27006469

Auteurs

Jaemyun Kim (J)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.

Seungwon Ji (S)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.

Jin-Young Lee (JY)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.

Jean Lorquin (J)

Institut Méditerranéen d'Océanologie, 163 Avenue de Luminy, CEDEX 09, 13288 Marseille, France.

Barbora Orlikova-Boyer (B)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), BAM3 Pavillon 2, 6A Rue Nicolas-Ernest Barblé, L-1210 Luxembourg, Luxembourg.

Claudia Cerella (C)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), BAM3 Pavillon 2, 6A Rue Nicolas-Ernest Barblé, L-1210 Luxembourg, Luxembourg.

Aloran Mazumder (A)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.

Florian Muller (F)

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), BAM3 Pavillon 2, 6A Rue Nicolas-Ernest Barblé, L-1210 Luxembourg, Luxembourg.

Mario Dicato (M)

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), BAM3 Pavillon 2, 6A Rue Nicolas-Ernest Barblé, L-1210 Luxembourg, Luxembourg.

Olivier Detournay (O)

Planktovie SAS, 45 Rue Frédéric Joliot Curie, CEDEX 13, 13013 Marseille, France.

Marc Diederich (M)

Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH